Name: Latest research reports of Divi's Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 4
Author: ICICI Securities Limited

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	25 Sep 2025	Divi's Laboratories	Consensus Share Price Target	5897.00	6410.70	-	8.71	hold	pdf Detailed Estimates
	08 Nov 2022	Divi's Laboratories	ICICI Securities Limited Target	5897.00	3893.00	3414.55 (72.70%)	Target met	Accumulate	pdf post cache	Broker Report Margin dips on fall in revenue ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q2FY23 performance was sharply below our estimates. Consolidated revenue fell 6.7% YoY to Rs18.5bn (I-Sec: Rs22.9bn), EBITDA margin slipped 770bps YoY to 33.5% (I-Sec: 41.2%) and adjusted PAT declined 18.6% YoY to Rs4.9bn (I-Sec: Rs6.2bn). pdf Copy Link Share on Share on Share on Share on Alert
	03 Oct 2022	Divi's Laboratories	Ashika Research Target	5897.00	4110.00	3726.85 (58.23%)		Buy	pdf post cache	Broker Report Ashika - Stock Picks Divi's Laboratories Ltd. - October 2022 Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
	25 Aug 2022	Divi's Laboratories	Geojit BNP Paribas Target	5897.00	4006.00	3587.50 (64.38%)		Buy	pdf post cache	Broker Report DIVI' S LAB Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2022	Divi's Laboratories	ICICI Securities Limited Target	5897.00	4173.00	3726.20 (58.26%)		Accumulate	pdf post cache	Broker Report Recovery in API; margins hit ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q1FY23 performance was a mixed bag with revenue ahead of our estimates while margin was lower. pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2022	Divi's Laboratories	Prabhudas Lilladhar Target	5897.00	4140.00	3732.00 (58.01%)		Accumulate	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Divi's Laboratories	BOB Capital Markets Ltd.	5897.00	4250.00	3726.20 (58.26%)		Hold	pdf post cache	Broker Report Divi's Labs (HOLD): No respite in sight for margins BOB Capital Markets Ltd. Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below pdf Copy Link Share on Share on Share on Share on Alert
	12 Aug 2022	Divi's Laboratories	ICICI Direct Target	5897.00	4315.00	3726.20 (58.26%)		Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2022	Divi's Laboratories	SMC online	5897.00		3514.70 (67.78%)		Results Update	pdf post cache	Broker Report Divis Laboratories Limited SMC online pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2022	Divi's Laboratories	ICICI Direct	5897.00	4655.00	3661.70 (61.05%)		Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2022	Divi's Laboratories	ICICI Securities Limited Reco Target	5897.00	4361.00	3897.90 (51.29%)		Accumulate	pdf post cache	Broker Report Beat on all fronts ICICI Securities Limited The strong growth was led by the custom synthesis division most likely due to higher than expected revenues from Molnupiravir. API segment continues its weak performance due to intense pricing pressures. pdf Copy Link Share on Share on Share on Share on Alert
more loading

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 6414.33. The consensus estimate represents an upside of 8.77% from the last price of 5897. View 9 reports from 6 analysts offering long-term price targets for Divi's Laboratories Ltd..

Margin dips on fall in revenue

Ashika - Stock Picks Divi's Laboratories Ltd. - October 2022

DIVI' S LAB

Recovery in API; margins hit

DIVI'S LABORATORIES

Divi's Labs (HOLD): No respite in sight for margins

Divi's Laboratories

Divis Laboratories Limited

Divi's Laboratories

Beat on all fronts

Advisor Screeners